Head: Natacha BROUCQSAULT
Cell reprogramming and differentiation facility
The rarity of the different syndromes, our close connection with clinicians and our capacity to handle hiPSCs production, characterization, differentiation and end-user training greatly facilitate the development of in vitro cellular models of rare disease, in particular for the exploration of tissues which are not otherwise accessible.
This unique situation gathering clinical management of patients and technological tools availability, led us to set a new facility to make our knowhow available to collaborative laboratories and open access to reprogramming technique for scientific community.
Our overall goal is to benefit patients and open new perspectives for the exploration of patho-mechanisms of these different diseases, identification of biomarkers and development of therapeutic strategies.
Our services
Form reprogramming request
FO_MASC_DEMANDE_REPRO_PRESTA_EXTERNES
Differentiation proposed by the MaSC facility
Inquiry for Cell reprogramming and differentiation facility
Interested in our reprogramming and differentiation services? Please fill the form below, your inquiry will be treated as soon as possible and you will be contacted by our team.
If you are amU staff please opt to send us directly an email : mmg-plateforme-masc-contact@univ-amu.fr
First name * Last name * Grade, job position Email * Email confirmation * Phone number Center, Unit, Company * Address * You are interested in: * Cell reprogramming Supply of iPS control cells Production of hiPSCs lines by the Crispr / cas9 technique Training Characterization of hiPSCs Cell differentiation (neuronal progenitor, fibroblast, etc) Other Message Submit
